10/19/2005 5:08:50 PM
IVAX Corporation (AMEX:IVX) (LSE:IVX.L) announced today that Jesus Leal has joined IVAX' subsidiary, IVAX Laboratories, as President. IVAX Laboratories is a U.S. proprietary pharmaceuticals company that markets IVAX' current U.S. proprietary products such as prescription drugs for allergies, coughs and colds; Nasarel(R) for allergic rhinitis; and QVAR(R) for asthma; and is positioned to market the future products that emerge from IVAX' research pipeline. Mr. Leal will report to Neil Flanzraich, vice chairman and president, of IVAX Corporation.
comments powered by